Because only a few patients carry BCL2L13 genetic changes, the impact of these changes on prognosis of ccRCC and pRCC is undeterminable due to limited patient numbers (Additional file 6). The gene discussed is BCL2L13; the disease is nonpapillary renal cell carcinoma.